Transfusion of CMV‐unselected blood components may lead to inappropriate donor selection for patients subsequently undergoing allogeneic stem cell transplant

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-3148|25|6|411-413

ISSN： 0958-7578

Source： TRANSFUSION MEDICINE, Vol.25, Iss.6, 2015-12, pp. : 411-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transfusion in CMV seronegative T‐depleted allogeneic stem cell transplant recipients with CMV‐unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction: a UK dual centre experience

By  

TRANSFUSION MEDICINE, Vol. 25, Iss. 6, 2015-12 ,pp. : 418-423

John Wiley & Sons Inc

Access to resources Recommend Favorite

Provision of cellular blood components to CMV‐seronegative patients undergoing allogeneic stem cell transplantation in the UK: survey of UK transplant centres

By  

TRANSFUSION MEDICINE, Vol. 27, Iss. 6, 2017-12 ,pp. : 444-450

John Wiley & Sons Inc

Access to resources Recommend Favorite

Controversies related to red blood cell transfusion in critically ill patients

By Prittie Jennifer E.  

Journal of Veterinary Emergency and Critical Care, Vol. 20, Iss. 2, 2010-04 ,pp. : 167-176

Blackwell Publishing

Access to resources Recommend Favorite

Use of non‐irradiated blood components in Campath (alemtuzumab)‐treated renal transplant patients

By  

TRANSFUSION MEDICINE, Vol. 26, Iss. 2, 2016-04 ,pp. : 138-146

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of Rh (D) alloimmunisation after Rh (D) positive platelet transfusions in patients undergoing haematopoietic stem cell transplantation

By  

TRANSFUSION MEDICINE, Vol. 25, Iss. 1, 2015-02 ,pp. : 49-50

John Wiley & Sons Inc

Access to resources Recommend Favorite